TcrossGlobal

Long-Term Outcomes with PCI Guided by Fractional Flow Reserve: 10 Years Follow-up of the FAME 2 Trial

The 10-year follow-up of the FAME 2 trial demonstrated that treatment with FFR-guided PCI and medical therapy in patients with stable coronary artery disease had better long-term outcomes than medical therapy alone, according to a presented by Dr. Carlos Collet, Cardiovascular Center OLV Aalst, Belgium, in the Hot Line session at ESC Congress 2024.

In the FAME 2 trial, 1,220 patients with stable coronary artery disease scheduled for PCI using DES...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.